SCHEMBL21625146

SCHEMBL21625146

CNCCN(C)C(=O)c1nn(-c2ccccc2)c2c1CCc1sccc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA2D1 P54289 2/20 0.41
▸ SHMT2 P34897 2/20 0.41
▸ PIK3CD O00329 8/20 0.39
▸ PIK3R2 O00459 8/20 0.39
▸ PIK3CA P42336 8/20 0.39
▸ PIK3CB P42338 8/20 0.39
▸ PIK3CG P48736 8/20 0.39
▸ PIK3R5 Q8WYR1 8/20 0.39
▸ PIK3R3 Q92569 8/20 0.39
▸ CCNA2 P20248 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CCNA1 P78396 2/20 0.38
▸ RAD52 P43351 1/20 0.34
▸ RIPK1 Q13546 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GRIA2 P42262 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21625205 0.88 SHMT2 (0.42) CACNA2D1SHMT2PIK3CDPIK3R2PIK3CA
SCHEMBL21625053 0.87 NR1H4 (0.46) CACNA2D1SHMT2PIK3CDPIK3R2PIK3CA
SCHEMBL21625120 0.83 SHMT2 (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21636277 0.83 GRIA2 (0.37) CACNA2D1SHMT2PIK3CAPIK3CGCCNA2
SCHEMBL21625155 0.82 SHMT2 (0.42) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625073 0.82 SHMT2 (0.48) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625114 0.76 CDK2 (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625090 0.76 SHMT2 (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625157 0.74 SHMT2 (0.59) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21636241 0.72 HIF1A (0.43) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO claimed
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
Send feedback